ETF Research

BIB: PROSHARES ULTRA NASDAQ BIOTECHNOLOGY

Generated from StockValueFinder data · Updated Oct 11, 2026 11:27 PM
Educational content only. This is not financial advice and is not a recommendation to buy, sell, or hold any ETF.

Share-split context: A forward split was recorded on May 20, 2015 with coefficient 2. A forward split turns each old share into multiple new shares and lowers the quoted price per share proportionally. Proportional ownership is unchanged at the split moment, so the split itself creates neither a gain nor a loss. The price-return figures in this report are already split-adjusted.

What this ETF is trying to do

The ProShares Ultra Nasdaq Biotechnology ETF (BIB) is a leveraged ETF. This means it uses financial tools to try and amplify the returns of the Nasdaq Biotechnology Index. It focuses on companies in the biotech sector, which create new medicines and healthcare technologies.

What the numbers show

Because this ETF has a history of share splits, we look at split-adjusted returns to see how it has performed.

• Price Return: This measures only the change in the share price. The one-year price return is approximately 66.78%, and the three-year price return is approximately 123.09%. Year-to-date (YTD), the price return is approximately 34.70%.

• Total Return: This reflects the overall return, including distributions. The one-year total return is approximately 67.19%, and the three-year total return is approximately 129.39%. The YTD total return is approximately 34.81%.

The current share price is $107.46 as of October 7, 2026.

Income and distribution explanation

This ETF provides cash distributions, but they are irregular and less frequent. Over the last 12 months, there were 3 payouts. The distribution yield is approximately 0.21%.

It is important for new investors to know that a distribution yield is not the same as a total return. While distributions provide cash income, they do not guarantee that the original investment value (the principal) will stay the same.

NAV Erosion Explanation

"NAV erosion" happens when the value of the fund's underlying assets declines over time. For this ETF, the erosion-risk score is 100, and the erosion severity is labeled as "good." The data indicates that no price erosion was detected, and the severe erosion-risk flag is false.

Top Holdings

Holdings can change over time. As of October 8, 2026, the top holdings (which are a partial list) include:

• CTE ProShares Trust M: 20.77%

• Nasdaq Biotechnology Index Swap: 15.28%

• Cash: 6.84%

• ProShares Genius Money Market ETF: 4.72%

• Amgen Inc: 4.34%

• Vertex Pharmaceuticals Inc: 4.08%

• Gilead Sciences Inc: 3.63%

• Regeneron Pharmaceuticals Inc: 2.73%

• Moderna Inc: 2.18%

• Nasdaq Bio Index Swap: 1.84%

Pros

• Strong split-adjusted price and total returns over the last one and three years.

• No price erosion detected according to the erosion-risk score.

Cons

• Very low distribution yield.

• Irregular payout schedule.

Beginner takeaway

BIB is a leveraged fund, which is different from a standard ETF. While it has shown significant price growth recently, it provides very little cash income. Investors often look for principal stability to ensure their initial investment doesn't shrink, and while this fund currently has a "good" erosion score, leveraged ETFs generally behave differently than traditional investments.

Top Holdings

Structured portfolio holdings supplied by the ETF data provider. These figures are not generated by the AI article.

256 holdings available
# Holding Ticker Weight
1 CTE PROSHARES TRUST M n/a 20.77%
2 NASDAQ BIOTECHNOLOGY INDEX SWAP n/a 15.28%
3 CASH n/a 6.84%
4 PROSHARES GENIUS MONEY MARKET ETF IQMM 4.72%
5 AMGEN INC AMGN 4.34%
6 VERTEX PHARMACEUTICALS INC VRTX 4.08%
7 GILEAD SCIENCES INC GILD 3.63%
8 REGENERON PHARMACEUTICALS INC REGN 2.73%
9 MODERNA INC MRNA 2.18%
10 NASDAQ BIO INDEX SWAP n/a 1.84%
Show all 256 holdings
1. CTE PROSHARES TRUST M n/a 20.77%
2. NASDAQ BIOTECHNOLOGY INDEX SWAP n/a 15.28%
3. CASH n/a 6.84%
4. PROSHARES GENIUS MONEY MARKET ETF IQMM 4.72%
5. AMGEN INC AMGN 4.34%
6. VERTEX PHARMACEUTICALS INC VRTX 4.08%
7. GILEAD SCIENCES INC GILD 3.63%
8. REGENERON PHARMACEUTICALS INC REGN 2.73%
9. MODERNA INC MRNA 2.18%
10. NASDAQ BIO INDEX SWAP n/a 1.84%
11. REVOLUTION MEDICINES INC ORDINARY SHARES RVMD 1.44%
12. BIOGEN INC BIIB 1.03%
13. ALNYLAM PHARMACEUTICALS INC ALNY 1.02%
14. ILLUMINA INC ILMN 0.98%
15. ARGENX SE ADR ARGX 0.90%
16. INSMED INC INSM 0.89%
17. ROYALTY PHARMA PLC CLASS A RPRX 0.86%
18. ROIVANT SCIENCES LTD ORDINARY SHARES ROIV 0.85%
19. INCYTE CORP INCY 0.81%
20. UNITED THERAPEUTICS CORP UTHR 0.71%
21. GUARDANT HEALTH INC GH 0.68%
22. VIATRIS INC VTRS 0.60%
23. MEDPACE HOLDINGS INC MEDP 0.55%
24. BRIDGEBIO PHARMA INC BBIO 0.52%
25. ASCENDIS PHARMA AS ASND 0.50%
26. JAZZ PHARMACEUTICALS PLC JAZZ 0.50%
27. NEUROCRINE BIOSCIENCES INC NBIX 0.49%
28. EXELIXIS INC EXEL 0.43%
29. BIOMARIN PHARMACEUTICAL INC BMRN 0.42%
30. BIONTECH SE ADR BNTX 0.41%
31. ARROWHEAD PHARMACEUTICALS INC ARWR 0.40%
32. HALOZYME THERAPEUTICS INC HALO 0.40%
33. BEONE MEDICINES LTD ADR ONC 0.39%
34. MADRIGAL PHARMACEUTICALS INC MDGL 0.39%
35. AXSOME THERAPEUTICS INC AXSM 0.35%
36. n/a PRAX 0.34%
37. SANOFI SA ADR SNY 0.34%
38. TEMPUS AI INC CLASS A COMMON STOCK TEM 0.34%
39. CYTOKINETICS INC CYTK 0.33%
40. KYMERA THERAPEUTICS INC ORDINARY SHARES KYMR 0.33%
41. IONIS PHARMACEUTICALS INC IONS 0.32%
42. KRYSTAL BIOTECH INC KRYS 0.32%
43. SUMMIT THERAPEUTICS INC ORDINARY SHARES SMMT 0.32%
44. PROTAGONIST THERAPEUTICS INC PTGX 0.31%
45. SPYRE THERAPEUTICS INC SYRE 0.30%
46. IMMUNOVANT INC IMVT 0.29%
47. VAXCYTE INC ORDINARY SHARES PCVX 0.29%
48. CRINETICS PHARMACEUTICALS INC CRNX 0.28%
49. TWIST BIOSCIENCE CORP TWST 0.28%
50. IMMUNITYBIO INC ORDINARY SHARES IBRX 0.27%
51. ALKERMES PLC ALKS 0.26%
52. APOGEE THERAPEUTICS INC APGE 0.26%
53. RHYTHM PHARMACEUTICALS INC RYTM 0.25%
54. n/a TXG 0.23%
55. ABIVAX SA ADR ABVX 0.22%
56. CG ONCOLOGY INC CGON 0.22%
57. ORUKA THERAPEUTICS INC ORKA 0.21%
58. SCHOLAR ROCK HOLDING CORP SRRK 0.21%
59. CARIS LIFE SCIENCES INC CAI 0.20%
60. COGENT BIOSCIENCES INC COGT 0.20%
61. MIRUM PHARMACEUTICALS INC MIRM 0.20%
62. PTC THERAPEUTICS INC PTCT 0.19%
63. TRAVERE THERAPEUTICS INC ORDINARY SHARES TVTX 0.19%
64. XENON PHARMACEUTICALS INC XENE 0.19%
65. CRISPR THERAPEUTICS AG CRSP 0.18%
66. ERASCA INC ERAS 0.18%
67. LIGAND PHARMACEUTICALS INC LGND 0.18%
68. n/a AMRX 0.18%
69. ACADIA PHARMACEUTICALS INC ACAD 0.16%
70. EDGEWISE THERAPEUTICS INC EWTX 0.16%
71. n/a DFTX 0.16%
72. n/a INDV 0.15%
73. AMYLYX PHARMACEUTICALS INC AMLX 0.14%
74. DYNE THERAPEUTICS INC ORDINARY SHARES DYN 0.14%
75. RELAY THERAPEUTICS INC ORDINARY SHARES RLAY 0.14%
76. ADAPTIVE BIOTECHNOLOGIES CORP ADPT 0.13%
77. DENALI THERAPEUTICS INC DNLI 0.13%
78. STRUCTURE THERAPEUTICS INC ADR GPCR 0.13%
79. ABCELLERA BIOLOGICS INC ORDINARY SHARES ABCL 0.12%
80. n/a KNSA 0.12%
81. TANGO THERAPEUTICS INC TNGX 0.12%
82. ENLIVEN THERAPEUTICS INC ELVN 0.11%
83. IDEAYA BIOSCIENCES INC IDYA 0.11%
84. IOVANCE BIOTHERAPEUTICS INC IOVA 0.11%
85. NEWAMSTERDAM PHARMA CO NV NAMS 0.11%
86. VERACYTE INC VCYT 0.11%
87. DISC MEDICINE INC ORDINARY SHARES IRON 0.10%
88. GRAIL INC GRAL 0.10%
89. MBX BIOSCIENCES INC MBX 0.10%
90. n/a TARS 0.10%
91. n/a ARQT 0.10%
92. UNIQURE NV QURE 0.10%
93. ALUMIS INC ALMS 0.09%
94. ATAIBECKLEY INC ATAI 0.09%
95. BEAM THERAPEUTICS INC BEAM 0.09%
96. NURIX THERAPEUTICS INC ORDINARY SHARES NRIX 0.09%
97. SUPERNUS PHARMACEUTICALS INC SUPN 0.09%
98. BIOCRYST PHARMACEUTICALS INC BCRX 0.08%
99. GENMAB AS ADR GMAB 0.08%
100. KODIAK SCIENCES INC KOD 0.08%
101. OCULAR THERAPEUTIX INC OCUL 0.08%
102. PHARVARIS NV ORDINARY SHARES PHVS 0.08%
103. PRECIGEN INC PGEN 0.08%
104. TREVI THERAPEUTICS INC TRVI 0.08%
105. ULTRAGENYX PHARMACEUTICAL INC RARE 0.08%
106. UROGEN PHARMA LTD n/a 0.08%
107. ADMA BIOLOGICS INC ADMA 0.07%
108. AGIOS PHARMACEUTICALS INC AGIO 0.07%
109. AURINIA PHARMACEUTICALS INC AUPH 0.07%
110. MINERALYS THERAPEUTICS INC MLYS 0.07%
111. n/a HRMY 0.07%
112. NOVOCURE LTD NVCR 0.07%
113. RAPPORT THERAPEUTICS INC RAPP 0.07%
114. SAREPTA THERAPEUTICS INC SRPT 0.07%
115. VERA THERAPEUTICS INC CLASS A VERA 0.07%
116. VERICEL CORP VCEL 0.07%
117. ANI PHARMACEUTICALS INC ANIP 0.06%
118. COMPASS PATHWAYS PLC ADR CMPS 0.06%
119. GH RESEARCH PLC GHRS 0.06%
120. INTELLIA THERAPEUTICS INC NTLA 0.06%
121. LEGEND BIOTECH CORP ADR LEGN 0.06%
122. n/a TSHA 0.06%
123. RECURSION PHARMACEUTICALS INC CLASS A RXRX 0.06%
124. SEPTERNA INC SEPN 0.06%
125. STOKE THERAPEUTICS INC STOK 0.06%
126. SYNDAX PHARMACEUTICALS INC SNDX 0.06%
127. XENCOR INC XNCR 0.06%
128. ZENAS BIOPHARMA INC ZBIO 0.06%
129. ZYMEWORKS INC REGISTERED SHS ZYME 0.06%
130. ABSCI CORP ABSI 0.05%
131. ANAPTYSBIO INC ANAB 0.05%
132. BICARA THERAPEUTICS INC BCAX 0.05%
133. ETON PHARMACEUTICALS INC ETON 0.05%
134. FIRST TRACKS BIOTHERAPEUTICS INC TRAX 0.05%
135. FORTREA HOLDINGS INC FTRE 0.05%
136. HARROW INC HROW 0.05%
137. IMMUNOCORE HOLDINGS PLC ADR IMCR 0.05%
138. INHIBRX BIOSCIENCES INC INBX 0.05%
139. INNOVIVA INC INVA 0.05%
140. MAZE THERAPEUTICS INC MAZE 0.05%
141. NOVAVAX INC NVAX 0.05%
142. ORIC PHARMACEUTICALS INC ORIC 0.05%
143. PERSONALIS INC PSNL 0.05%
144. TYRA BIOSCIENCES INC TYRA 0.05%
145. VIR BIOTECHNOLOGY INC VIR 0.05%
146. XERIS BIOPHARMA HOLDINGS INC XERS 0.05%
147. ALVOTECH ALVO 0.04%
148. ARRIVENT BIOPHARMA INC AVBP 0.04%
149. CORVUS PHARMACEUTICALS INC CRVS 0.04%
150. CULLINAN THERAPEUTICS INC CGEM 0.04%
151. KURA ONCOLOGY INC KURA 0.04%
152. MANNKIND CORP MNKD 0.04%
153. MEIRAGTX HOLDINGS PLC MGTX 0.04%
154. MONTE ROSA THERAPEUTICS INC GLUE 0.04%
155. OMEROS CORP OMER 0.04%
156. REPLIMUNE GROUP INC REPL 0.04%
157. SANA BIOTECHNOLOGY INC ORDINARY SHARES SANA 0.04%
158. SAVARA INC SVRA 0.04%
159. VOR BIOPHARMA INC ORDINARY SHARES VOR 0.04%
160. ACLARIS THERAPEUTICS INC ACRS 0.03%
161. AMPHASTAR PHARMACEUTICALS INC AMPH 0.03%
162. ANNEXON INC ORDINARY SHARES ANNX 0.03%
163. ARBUTUS BIOPHARMA CORP ABUS 0.03%
164. ARDELYX INC ARDX 0.03%
165. AURA BIOSCIENCES INC AURA 0.03%
166. CANDEL THERAPEUTICS INC CADL 0.03%
167. CASTLE BIOSCIENCES INC CSTL 0.03%
168. COLLEGIUM PHARMACEUTICAL INC COLL 0.03%
169. DESIGN THERAPEUTICS INC DSGN 0.03%
170. GERON CORP GERN 0.03%
171. GRIFOLS SA ADR GRFS 0.03%
172. JANUX THERAPEUTICS INC ORDINARY SHARES JANX 0.03%
173. MESOBLAST LTD ADR MESO 0.03%
174. n/a FDMT 0.03%
175. n/a MRVI 0.03%
176. n/a OLMA 0.03%
177. PACIRA BIOSCIENCES INC PCRX 0.03%
178. RIGEL PHARMACEUTICALS INC RIGL 0.03%
179. SOLID BIOSCIENCES INC SLDB 0.03%
180. THERAVANCE BIOPHARMA INC TBPH 0.03%
181. WAVE LIFE SCIENCES INC WVE 0.03%
182. ZAI LAB LTD ADR REPR 1 SHS ZLAB 0.03%
183. ALLOGENE THERAPEUTICS INC ALLO 0.02%
184. ALTIMMUNE INC ALT 0.02%
185. AQUESTIVE THERAPEUTICS INC AQST 0.02%
186. ARS PHARMACEUTICALS INC SPRY 0.02%
187. ARVINAS INC ARVN 0.02%
188. AUTOLUS THERAPEUTICS PLC ADR AUTL 0.02%
189. BIOAGE LABS INC BIOA 0.02%
190. CABALETTA BIO INC ORDINARY SHARES CABA 0.02%
191. CORMEDIX INC CRMD 0.02%
192. CYTOMX THERAPEUTICS INC CTMX 0.02%
193. EDITAS MEDICINE INC EDIT 0.02%
194. EVOLUS INC EOLS 0.02%
195. EYEPOINT INC EYPT 0.02%
196. IRONWOOD PHARMACEUTICALS INC CLASS A IRWD 0.02%
197. KYVERNA THERAPEUTICS INC KYTX 0.02%
198. n/a SGMT 0.02%
199. n/a PHAT 0.02%
200. n/a CTNM 0.02%
201. NEUROGENE INC NGNE 0.02%
202. OMNIAB INC OABI 0.02%
203. PHIBRO ANIMAL HEALTH CORP CLASS A PAHC 0.02%
204. PRIME MEDICINE INC PRME 0.02%
205. PROTHENA CORP PLC PRTA 0.02%
206. PUMA BIOTECHNOLOGY INC PBYI 0.02%
207. REGENXBIO INC RGNX 0.02%
208. SILENCE THERAPEUTICS PLC ADR SLN 0.02%
209. TECTONIC THERAPEUTIC INC TECX 0.02%
210. ZEVRA THERAPEUTICS INC ZVRA 0.02%
211. AC IMMUNE SA ACIU 0.01%
212. ALPHA TEKNOVA INC TKNO 0.01%
213. ANAVEX LIFE SCIENCES CORP AVXL 0.01%
214. ARCTURUS THERAPEUTICS HOLDINGS INC ARCT 0.01%
215. ATEA PHARMACEUTICALS INC ORDINARY SHARES AVIR 0.01%
216. BICYCLE THERAPEUTICS PLC ADR BCYC 0.01%
217. C4 THERAPEUTICS INC ORDINARY SHARES CCCC 0.01%
218. CARIBOU BIOSCIENCES INC ORDINARY SHARES CRBU 0.01%
219. COHERUS ONCOLOGY INC CHRS 0.01%
220. ENANTA PHARMACEUTICALS INC ENTA 0.01%
221. ENTRADA THERAPEUTICS INC TRDA 0.01%
222. FOGHORN THERAPEUTICS INC ORDINARY SHARES FHTX 0.01%
223. FULCRUM THERAPEUTICS INC FULC 0.01%
224. HUMACYTE INC HUMA 0.01%
225. IMMUNEERING CORP CLASS A IMRX 0.01%
226. INVIVYD INC ORDINARY SHARES IVVD 0.01%
227. KAMADA LTD n/a 0.01%
228. KEROS THERAPEUTICS INC KROS 0.01%
229. LAKEFRONT BIOTHERAPEUTICS NV ADR LKFT 0.01%
230. LARIMAR THERAPEUTICS INC LRMR 0.01%
231. LEXEO THERAPEUTICS INC LXEO 0.01%
232. LIFECORE BIOMEDICAL INC LFCR 0.01%
233. LYELL IMMUNOPHARMA INC ORDINARY SHARES LYEL 0.01%
234. NEUMORA THERAPEUTICS INC NMRA 0.01%
235. NOVABRIDGE BIOSCIENCES ADR NBP 0.01%
236. ORCHESTRA BIOMED HOLDINGS INC OBIO 0.01%
237. PACIFIC BIOSCIENCES OF CALIFORNIA INC PACB 0.01%
238. PEPGEN INC PEPG 0.01%
239. PYXIS ONCOLOGY INC PYXS 0.01%
240. ROCKET PHARMACEUTICALS INC RCKT 0.01%
241. SIGA TECHNOLOGIES INC SIGA 0.01%
242. SIONNA THERAPEUTICS INC SION 0.01%
243. UPSTREAM BIO INC UPB 0.01%
244. VANDA PHARMACEUTICALS INC VNDA 0.01%
245. VOYAGER THERAPEUTICS INC VYGR 0.01%
246. AARDVARK THERAPEUTICS INC AARD 0.00%
247. BLACK DIAMOND THERAPEUTICS INC ORDINARY SHARES BDTX 0.00%
248. CARTESIAN THERAPEUTICS ([WTS/RTS]) 0% n/a 0.00%
249. CODEXIS INC CDXS 0.00%
250. GOSSAMER BIO INC GOSS 0.00%
251. JYONG BIOTECH LTD MENS 0.00%
252. LENZ THERAPEUTICS INC LENZ 0.00%
253. QUANTUM-SI INC ORDINARY SHARES CLASS A QSI 0.00%
254. RANI THERAPEUTICS HOLDINGS INC CLASS A RANI 0.00%
255. TENAYA THERAPEUTICS INC TNYA 0.00%
256. THIRD HARMONIC BIO INC n/a 0.00%
Holdings data last updated Oct 8, 2026 5:20 AM .
Scroll to Top